|
EQS-Ad-hoc: MEDICLIN AG / Key word(s): Forecast/Annual Results Offenburg, 21 January 2025
MEDICLIN raises full-year guidance for the 2024 financial year MEDICLIN Aktiengesellschaft MED announces that it is raising its guidance for the 2024 financial year. Instead of a Group EBIT* between EUR 33.0 and 39.0 million, MEDICLIN now expects a Group EBIT between EUR 48.0 and 54.0 million. The sales forecast for the Group was raised from -2.0 % to 0.0 % to now 1.0 % to 3.0 %. The preliminary figures for the fourth quarter and the 2024 financial year will be published on 27 February 2025. * As defined on the company's website at the following link Contact for further information: MEDICLIN Aktiengesellschaft Okenstraße 27 77652 Offenburg Ender Gülcan Head of Investor Relations and Sustainability Tel.: 0781/488-326 Fax: 0781/488-184 ender.guelcan@mediclin.de www.mediclin.de End of Inside Information
21-Jan-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | MEDICLIN AG |
| Okenstraße 27 | |
| 77652 Offenburg | |
| Germany | |
| Phone: | +49 (0)781 488-326 |
| Fax: | +49 (0)781 488-184 |
| E-mail: | ender.guelcan@mediclin.de |
| Internet: | www.mediclin.de |
| ISIN: | DE0006595101 |
| WKN: | 659510 |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2071983 |
| End of Announcement | EQS News Service |
|
|
2071983 21-Jan-2025 CET/CEST
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
